NEW YORK, Feb. 9, 2011 /PRNewswire/ — Americord
Registry, a pioneer in cord blood and
placenta stem cell preservation, is proud to announce that it has
obtained a provisional human tissue cord blood banking license from
the New York State Department of Health, becoming the first private
umbilical cord blood bank headquartered in New York City with the
authority to collect umbilical cord blood in the state of New
York.
(Logo:
http://photos.prnewswire.com/prnh/20110209/NY44693LOGO)
“The New York State licensing requirements are very rigorous and
the license is one of the most difficult accreditations to earn.
Only the highest quality cord blood banks, such as The New York
Blood Center, which operates the oldest and largest public cord
blood bank, are able to meet these very strict requirements,” said
Martin Smithmyer, President and CEO of Americord.
Most states only require that cord blood banking organizations
register their in-state laboratories. New York, on the other hand,
licenses the organizations themselves, and requires them to follow
meticulous protocols before their labs can collect cord blood. With
this license, Americord is currently is able to accept cord blood
from nearly all 50 states, as well as many international
locations.
For more information about Americord
Registry, or to speak with Mr. Smithmyer, please contact Dana
Taormina at 973-732-3521 or
[email protected].
About Americord RegistryAmericord Registry is
a pioneer in cord blood and placenta stem cell preservation.
Americord collects, processes, and stores newborn stem cells from
umbilical cord blood for future medical or therapeutic use,
including the treatment of more than 75 blood diseases such a
‘/>”/>
SOURCE
